Female Genital Tract
Pathology · Topic 29
Source: NMC CBME Curriculum 2024 · Volume I · Pathology · Topic 29 · combined PDF page 200
Practice questions
- According to the ESUR guideline, which examination provides comprehensive evaluation of female genital tract congenital anomalies in a single examination?
- A radiologist is preparing a dedicated MRI protocol for a suspected female genital tract congenital anomaly. Which combination is specifically emphasized by the ESUR guideline?
- Why does the ESUR guideline support standardized MRI reporting for female genital tract congenital anomalies?
- A systematic review examining the relationship between the female genital tract microbiome and dysmenorrhoea included how many eligible articles and cases?
- What is the most evidence-calibrated conclusion from the systematic review of female genital tract microbiome findings in dysmenorrhoea?
- The systematic review of microbiome and dysmenorrhoea identified eligible studies published during which interval?
- In the female genital tract polyp GWAS meta-analysis, how many significant genomic risk loci were reported?
- Which biological processes were highlighted by genes prioritized in the female genital tract polyp GWAS?
- A researcher interprets the female genital tract polyp GWAS as proving that identified genetic loci cause endometrial cancer. Which response best reflects the study's findings?
- What limitation did the female genital tract polyp GWAS report regarding polyp subtypes?
- A particle is detected in a reproductive fluid, but there is no evidence of tissue localization or a corresponding lesion. Under the lesion-based evidence framework, what can most safely be concluded?
- Which set of findings would most strengthen a claim that microplastics are lesion-relevant in female genital tract tissue?
- Which additional feature is particularly important when moving from an observed association between microplastics and disease toward a causal claim?
- Which morphologic configuration was reported in all four somatic carcinomas with yolk sac tumor differentiation in the female genital tract series?
- In a female genital tract tumor with a suspected yolk sac tumor component, which immunohistochemical profile best matches the reported component in somatic carcinomas with yolk sac tumor differentiation?
- A female genital tract carcinoma has a morphologically suspected yolk sac tumor component, but Schiller-Duval bodies are not identified. Which interpretation is most appropriate in light of the reported series?
- According to the review of primary lymphomas of the female genital tract, which histologic subtype is most common?
- A patient has a pelvic mass and abnormal bleeding, and primary female genital tract lymphoma is in the differential diagnosis. Which diagnostic approach is described as valuable and potentially able to reduce unnecessary surgery?
- Which clinical feature is reported to be infrequent in primary lymphomas of the female genital tract?
- A woman with a history of cutaneous melanoma develops an ovarian mass that resembles an epithelial ovarian primary on imaging. Which interpretation is supported by the review of cutaneous malignancies metastatic to the female genital tract?
- Which metastatic pattern is described for cutaneous squamous cell carcinoma and Merkel cell carcinoma involving the female pelvis?
- Why is histologic evaluation with immunohistochemistry important when a patient with a skin cancer history develops a pelvic or genital tract mass?
- Which statement best distinguishes mesonephric-like adenocarcinoma from mesonephric adenocarcinoma?
- Which immunophenotypic pattern is most consistent with mesonephric-like adenocarcinoma as summarized in the review?
- Which molecular alteration is frequently reported in mesonephric-like adenocarcinoma?
- A uterine tumor has a mesonephric-like adenocarcinoma diagnosis. Which morphologic expectation is consistent with the review?